Trizidim Injection 500 mg/vial contains Ceftazidime Pentahydrate, a third-generation cephalosporin antibiotic with broad-spectrum activity against Gram-negative and certain Gram-positive bacteria. It is formulated for intravenous (IV) or intramuscular (IM) use, providing rapid and effective systemic delivery for the treatment of serious bacterial infections.

Ceftazidime, the active ingredient, inhibits bacterial cell wall synthesis, leading to bacterial cell death. Trizidim Injection is particularly effective against Pseudomonas aeruginosa, a common pathogen in hospital-acquired infections, as well as other resistant Gram-negative bacteria. It is widely used in respiratory tract infections, urinary tract infections, skin and soft tissue infections, sepsis, and complicated intra-abdominal infections.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Trizidim Injection 500 mg/vial is indicated for:

• Severe bacterial infections: Including pneumonia, urinary tract infections, skin and soft tissue infections, and bone and joint infections

• Sepsis and bacteremia: For systemic infections caused by susceptible organisms

• Complicated intra-abdominal infections: Often used in combination with other agents

• Pseudomonas infections: Particularly in immunocompromised patients or hospital-acquired infections

• Surgical prophylaxis: In select high-risk procedures as directed by a physician

Trizidim Injection is reserved for serious infections requiring parenteral therapy and should ideally be guided by culture and sensitivity tests.

Mechanism of Action

Ceftazidime Pentahydrate in Trizidim Injection acts as a beta-lactam antibiotic:

• Inhibits bacterial cell wall synthesis: Binds to penicillin-binding proteins (PBPs) to prevent peptidoglycan cross-linking

• Bactericidal effect: Causes lysis and death of susceptible bacteria

• Broad-spectrum activity: Effective against Gram-negative bacteria including Pseudomonas aeruginosa, Escherichia coli, Klebsiella species, and certain Gram-positive bacteria

• Beta-lactamase stability: Resistant to many bacterial beta-lactamases, making it effective in infections resistant to other cephalosporins

This mechanism ensures rapid and effective eradication of pathogenic bacteria, particularly in severe or hospital-acquired infections.

Dosage and Administration

• Adult dose: 500 mg to 2 g every 8–12 hours depending on infection severity

• Pediatric dose: Adjusted according to body weight and infection type; follow physician guidance

• Route of administration: IV injection over 3–5 minutes or IM injection after reconstitution

• Reconstitution: Dissolve the vial in sterile water or an appropriate diluent before use

• Duration of therapy: Typically 7–14 days depending on the infection type; longer therapy may be required in complicated cases

Precautions and Warnings

• Allergy: Avoid in patients with known hypersensitivity to cephalosporins or penicillin

• Renal impairment: Dose adjustment is necessary for patients with kidney dysfunction

• Gastrointestinal disturbances: Prolonged use may lead to superinfections, including Clostridium difficile-associated diarrhea

• Pregnancy and breastfeeding: Use only if clearly indicated by a physician

• Monitoring: Evaluate for allergic reactions, renal function, and treatment response

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Trizidim Injection is generally well tolerated. Possible side effects include:

• Injection site reactions: pain, swelling, or redness

• Gastrointestinal upset: nausea, vomiting, or diarrhea

• Allergic reactions: rash, itching, urticaria

• Rare: anaphylaxis, nephrotoxicity, hematological changes, or superinfections

Seek immediate medical attention if severe allergic reactions, difficulty breathing, or persistent diarrhea occur.

Storage

Store below 30°C, in a cool, dry place protected from light. Keep out of reach of children. Reconstituted solutions should be used immediately or stored as directed by healthcare professionals.

Trizidim Injection 500 mg/vial offers potent, fast-acting antibacterial therapy, making it an essential treatment for serious bacterial infections, including resistant hospital-acquired and systemic infections.